MarginsXMarginsX
Home › Markets › Health Care › SRTS

Sensus Healthcare Inc. (SRTS)

SRTS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.34
+0.65% on the day
Market cap
$38.5M
Nano cap
Revenue · 2025
$27.5M
-34.3% on 2024
Net income · 2025
-$7.7M
-28.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1494891/000175392626000435/0001753926-26-000435-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSRTS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2016
SEC CIK0001494891
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$27.5M
Net income-$7.7M
Operating income-$10.3M
Net margin-28.1%
Operating margin-37.5%
Revenue growth-34.3%
Cash$22.1M
Total assets$53.0M
P/E (computed)Net income was not positive
P/S (computed)1.4×

Warning signs

Cash runway
26.8 months
$15.2M cash at June 30, 2026
Share count, 1 year
+0.2%
2025-11-05 to 2026-11-10 · +0.5% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$729K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$15.2M cash; operating cash flow -$1.7M a quarter.Report 2026-06-30
Shares outstanding16,462,059 (2026-11-10); 16,425,036 a year earlier; 16,382,404 three years earlier.Cover page 2026-11-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCarr, Riggs & Ingram LLC, Palm Beach Gardens, Florida, United States; changed auditors 1 time in 24 months8-K 4.01 2026-01-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $729K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$2.3M-$8.7M-$3.1M$15.2MNo debt tags$17.5M10-Q 2026-08-14
Q1 2026
2026-03-31
$3.4M-$2.6M-$3.8M$18.3MNo debt tags$22.5M10-Q 2026-05-13
Q4 2025
2025-12-31
$4.9M-$3.2M-$2.2M$22.1MNo debt tags$27.5M10-K 2026-03-04
Q3 2025
2025-09-30
$6.9M-$943K$2.3M$24.5MNo debt tags$35.6M10-Q 2025-11-12
Q2 2025
2025-06-30
$7.3M-$1.0M$3.1M$22.2MNo debt tags$37.6M10-Q 2026-08-14
Q1 2025
2025-03-31
$8.3M-$2.6M-$2.7M$19.1MNo debt tags$39.5M10-Q 2026-05-13
Q4 2024
2024-12-31
$13.1M$1.5M-$827K$22.1MNo debt tags$41.8M10-K 2026-03-04
Q3 2024
2024-09-30
$8.8M$1.2M$4.0M$22.6MNo debt tags$41.3M10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32019-06-04
Latest annual report10-K2026-03-04
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-12
Latest proxyDEF 14A2026-04-29

Source: SEC EDGAR submissions feed, 409 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-18.7%
1 month-19.6%
3 months-26.4%
Year to date-41.6%
1 year-47.9%
From 52-week high-56.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
MDAISpectral AI Inc.$1.31+0.77%$42.2M
TELATELA Bio Inc.$0.7616-7.13%$34.4M
MBOTMicrobot Medical Inc.$0.6444-34.16%$43.3M
ADGMAdagio Medical Holdings Inc$1.61-16.58%$44.2M
NEPHNephros Inc.$3.00-1.64%$32.6M
DXRDaxor Corporation$8.36-0.89%$48.8M
XTNTXtant Medical Holdings Inc.$0.2098-22.78%$29.4M
NSPRInspireMD Inc.$0.6000-6.85%$28.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier